688520 神州細胞
按盤價 
40.380 +1.090 (+2.774%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -41.228 | 94.728 | 224.112 | -475.870 | -227.230 |
| 總資產報酬率 ROA (%) | 5.106 | -14.521 | -25.261 | -57.092 | -57.653 |
| 投入資產回報率 ROIC (%) | 6.334 | -18.787 | -35.586 | -85.652 | -58.440 | 邊際利潤分析 |
| 銷售毛利率 (%) | 96.283 | 97.110 | 96.689 | 94.761 | 81.944 |
| 營業利潤率 (%) | 27.369 | 0.337 | -34.958 | -637.576 | -217,561.313 |
| 息稅前利潤/營業總收入 (%) | 11.824 | -15.291 | -42.225 | -624.971 | -213,149.714 |
| 淨利潤/營業總收入 (%) | 7.765 | -21.026 | -50.827 | -646.514 | -217,591.211 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 317.626 | 5.636 | 75.009 | 102.089 | 107.663 |
| 價值變動淨收益/利潤總額(%) | 0.719 | -0.624 | -1.174 | -1.125 | -1.389 |
| 營業外收支淨額/利潤總額(%) | -252.452 | 101.604 | 31.223 | 1.383 | 0.014 | 償債能力分析 |
| 流動比率 (X) | 0.709 | 0.523 | 1.116 | 0.885 | 2.319 |
| 速動比率 (X) | 0.588 | 0.423 | 0.976 | 0.750 | 2.229 |
| 資產負債率 (%) | 104.243 | 122.285 | 108.852 | 116.822 | 64.631 |
| 帶息債務/全部投入資本 (%) | 95.026 | 114.832 | 69.035 | 98.459 | -- |
| 股東權益/帶息債務 (%) | -5.213 | -24.270 | -16.601 | -27.002 | 177.157 |
| 股東權益/負債合計 (%) | -3.891 | -18.032 | -7.946 | -14.120 | 54.953 |
| 利息保障倍數 (X) | 2.913 | -2.667 | -4.908 | -29.010 | -47.991 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 64.468 | 60.374 | 60.424 | 218.568 | 0.000 |
| 存貨周轉天數 (天) | 829.493 | 1,302.197 | 1,496.688 | 3,297.920 | 0.000 |
| 備註： | 即時報價更新時間為 20/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
